Evolent Health, Inc

Historical 13F Holders

Symbol
EVH
CUSIP
30050B101
All holders as of
Q1 2025
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 52 7.03 M $79.1 M
2025 Q1 240 125 M $1.18 B
2024 Q4 267 122 M $1.37 B
2024 Q3 300 132 M $3.73 B
2024 Q2 264 135 M $2.57 B
2024 Q1 269 132 M $4.32 B
2023 Q4 251 134 M $4.41 B
2023 Q3 217 122 M $3.34 B
2023 Q2 228 118 M $3.55 B
2023 Q1 255 112 M $3.62 B
2022 Q4 247 103 M $2.90 B
2022 Q3 273 95.6 M $3.43 B
2022 Q2 225 89.7 M $2.76 B
2022 Q1 235 86.6 M $2.79 B
2021 Q4 230 84.8 M $2.35 B
2021 Q3 241 85.9 M $2.66 B
2021 Q2 192 83.0 M $1.75 B
2021 Q1 182 82.0 M $1.66 B
2020 Q4 180 85.6 M $1.37 B
2020 Q3 168 80.0 M $997 M
2020 Q2 148 73.5 M $522 M
2020 Q1 170 78.6 M $434 M
2019 Q4 191 85.4 M $773 M
2019 Q3 196 84.9 M $610 M
2019 Q2 212 80.2 M $637 M
2019 Q1 206 81.1 M $1.02 B
2018 Q4 201 85.3 M $1.70 B
2018 Q3 208 84.1 M $2.39 B
2018 Q2 189 81.6 M $1.72 B
2018 Q1 165 79.7 M $1.13 B
2017 Q4 165 77.3 M $951 M
2017 Q3 175 73.8 M $1.32 B
2017 Q2 174 62.0 M $1.57 B
2017 Q1 144 41.7 M $925 M
2016 Q4 123 29.6 M $438 M
2016 Q3 115 27.3 M $679 M
2016 Q2 81 18.1 M $347 M
2016 Q1 70 16.5 M $174 M
2015 Q4 71 16.1 M $195 M
2015 Q3 70 15.9 M $254 M
2015 Q2 63 14.8 M $288 M